This site is intended for healthcare professionals only
LoginRegister
Received CDSCO nod for Nafithromycin Antibiotic for CABP, says WockhardtReceived CDSCO nod for Nafithromycin Antibiotic for CABP, says Wockhardt
Health Insurer, Star Health says it received $68,000 ransom demand after data leakHealth Insurer, Star Health says it received $68,000 ransom demand after data leak
Manufacturing Defects: Glenmark Subsidiary Recalls Products in USManufacturing Defects: Glenmark Subsidiary Recalls Products in US
Serum institute dengue treatmentSerum Institute of India gets CDSCO Panel nod to study Measles, Mumps, and Rubella Vaccine Live...
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITCCDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Tozorakimab Study
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJ&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition
Sun Pharma Halol facility gets OAI status from USFDARs 9.81 crore expenditure on Conference fees, accommodation to doctors, Business Promotion done by...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMSD Phase 3 trial of head and neck cancer treatment meets primary endpoint
Biotechnology to Drive Indias Next Industrial Revolution: Dr. Jitendra SinghBiotechnology to Drive India's Next Industrial Revolution: Dr. Jitendra Singh
Fortis Healthcare to Raise Rs 1,500 Crore Through NCDsFortis Healthcare to Raise Rs 1,500 Crore Through NCDs
Declare Cancer a Notifiable Disease, Bring Cancer Drugs Under Price Control: Parliamentary PanelAnti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means
Zydus, Synthon enters into licensing, supply agreement for multiple sclerosis drug Ozanimod for USZydus receives USFDA nod for Paliperidone ER Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg
X